GUTS - Fractyl Health, Inc. News

HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Fractyl Health (NASDAQ:GUTS) with a B

Fractyl Health Announces 1-Yr Results From Open-Label REVEAL-1 Cohort; Participants Retained ~78% Of

Participants retained ~78% of GLP-1 induced total body weight loss one year after discontinuation an

Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 We

Participants retained ~78% of GLP-1 induced total body weight loss one year after discontinuation an

Fractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategy

BURLINGTON, Mass., June 01, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Compan

Fractyl Health, Inc. (GUTS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

12 Health Care Stocks Moving In Wednesday's Intraday Session

Fractyl Health, Inc. (GUTS) Q1 2026 Earnings Call Transcript

marketbeat.com

Fractyl Health Q1 Earnings Call Highlights

Fractyl Health NASDAQ: GUTS said it remains on track to report pivotal data for its Revita therapy i

Fractyl Health Q1 2026 Earnings Call: Complete Transcript

Fractyl Health Q1 EPS $0.06 Beats $(0.16) Estimate

Fractyl Health (NASDAQ:GUTS) reported quarterly earnings of $0.06 per share which beat the analyst c

Fractyl Health Reports First Quarter 2026 Financial Results and Business Updates

Next anticipated Revita ® clinical data readouts are 1-year data from the REVEAL-1 Cohort in Q2 2026

Earnings Scheduled For May 12, 2026

Fractyl Health Receives Clinical Trial Application Authorization In Netherlands To Initiate Phase 1/

Authorization advances Fractyl Health to a dual clinical-stage company, with Revita in pivotal devel

Fractyl Health Authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gen

Authorization advances Fractyl Health to a dual clinical-stage company, with Revita ® in pivotal dev

Fractyl Health to Report First Quarter 2026 Financial Results and Provide Business Updates on May 12

BURLINGTON, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company

HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Fractyl Health (NASDAQ:GUTS) with a B

defenseworld.net

Fractyl Health, Inc. (NASDAQ:GUTS) Receives $5.40 Average Price Target from Analysts

Shares of Fractyl Health, Inc. (NASDAQ: GUTS - Get Free Report) have earned an average rating of "Ho

prnewswire.com

Scalable Biotech Manufacturing Unlocks a $14B Market

/PRNewswire/ -- USANewsGroup.com News Commentary - The global cell therapy manufacturing market is h

defenseworld.net

Fractyl Health Q4 Earnings Call Highlights

Fractyl Health (NASDAQ: GUTS) used its fourth-quarter and full-year 2025 results call to sharpen its

Fractyl Health (GUTS) Stock Jumps 21% After Hours: Here's What You Should Know

Fractyl Health's shares jumped 20.9% after hours following its Q4 2025 results and new weight-ma

Fractyl Health, Inc. (GUTS) Q4 2025 Earnings Call Transcript

Fractyl Health Q4 EPS $(0.07) Beats $(0.19) Estimate

Fractyl Health (NASDAQ:GUTS) reported quarterly losses of $(0.07) per share which beat the analyst c

Earnings Scheduled For March 24, 2026

Fractyl Health to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Up

BURLINGTON, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Compa

zacks.com

Fractyl Health, Inc. (GUTS) Moves to Buy: Rationale Behind the Upgrade

Fractyl Health, Inc. (GUTS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism

12 Health Care Stocks Moving In Friday's After-Market Session

Fractyl Health Completes Participant Randomization In REMAIN-1 Pivotal Cohort Evaluating Revita For

Topline 6-month pivotal data expected in early Q4 2026 with potential FDA marketing application subm

Fractyl Health Completes Randomization in REMAIN-1 Pivotal Cohort of Revita® for Post-GLP-1 Weight M

Topline 6-month pivotal data expected in early Q4 2026 with potential FDA marketing application subm

zacks.com

Fractyl Health, Inc. (GUTS) Loses 77.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Co

The heavy selling pressure might have exhausted for Fractyl Health, Inc. (GUTS) as it is technically

defenseworld.net

Short Interest in Fractyl Health, Inc. (NASDAQ:GUTS) Increases By 22.6%

Fractyl Health, Inc. (NASDAQ: GUTS - Get Free Report) was the recipient of a large growth in short i

Fractyl Health: Unreasonably Low Market Expectations Create A Trading Opportunity Towards 2026 Catal

Fractyl Health offers a buy-the-dip opportunity after an overreaction to underwhelming 6-month pilot

12 Health Care Stocks Moving In Monday's Pre-Market Session

Morgan Stanley Downgrades Fractyl Health to Equal-Weight, Lowers Price Target to $2

Morgan Stanley analyst Michael Ulz downgrades Fractyl Health (NASDAQ:GUTS) from Overweight to Equ

12 Health Care Stocks Moving In Friday's Intraday Session

businesswire.com

Fractyl Health, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your

LOS ANGELES--(BUSINESS WIRE)--Fractyl Health, Inc. Investigated on Behalf of Investors - Contact the

247wallst.com

Here Are Friday’s Top Wall Street Analyst Research Calls: Broadcom, Circle Internet, Kenvue, Medtron

Pre-Market Stock Futures: Futures are trading lower as we prepare to close out the trading week. Wha

Fractyl Health Shares Drop, Eyes New FDA Route For Its Lead Product

Fractyl Health stock plunged after the company signaled a possible FDA path change for its Revita de

Crude Oil Surges 3%; Caterpillar Shares Gain After Q4 Results

12 Health Care Stocks Moving In Thursday's Intraday Session

US Stocks Mixed; Tesla Posts Upbeat Q4 Earnings

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Fractyl Health Announces 6-Month Randomized Results From Ongoing REMAIN-1 Midpoint Cohort, Blinded,

Revita-treated patients experienced sustained weight maintenance, improved cardiometabolic profile,

Fractyl Health Outlines Its Strategic Outlook For 2026, Highlighting Anticipated Clinical And Regula

RevitaIn 2026, the Company plans to advance Revita through a series of important clinical and regula

Lightwave Logic, Kyverna Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Sess

Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket

Fractyl Health Calls All 17,063,073 Warrants For Cancellation For Cash: Exercise At $1.05, If Fully

Fractyl Health, Inc. (NASDAQ:GUTS) (the "Company" or "Fractyl"), a metabolic therape

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Tuesday's After-Market Session

Fractyl Health's Revita Procedure Helps Patients Keep Weight Off After Stopping GLP-1 Drugs

Fractyl Health (NASDAQ: GUTS) released positive 6-month results from its REVEAL-1 study in obese pat